trifarotene (Aklief)

From Aaushi

Jump to navigation Jump to search

^[1]^[2]

Indications

acne (FDA-approved for patients >= 9 year)

Dosage

applied once daily
0.05 mg/mL Topical Cream [Aklief]

provided in a 45-gram pump

Adverse effects

application-site irritation
application-site pruritus
sunburn

Mechanism of action

topical retinoid
selectively targets retinoic acid receptor gamma (RAR-gamma)

More general terms

References

↑ RxNorm
↑ Brooks M Cite this: FDA OKs Trifarotene, First New Retinoid Acne Cream in 20 Years. Medscape - Oct 04, 2019. https://www.medscape.com/viewarticle/919500

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11518241

Retrieved from "https://aaushi.info/w/index.php?title=A55883&oldid=1162179"

↑ Back to top